Drexel University - Comprehensive, integrated academics enhanced by co-operative education, technology, and research opportunities. | Drexel University
Drexel University
Search events. View events.

All Categories

Click for help in using calendar displays. Print the contents of the current screen.
Display Format: 
Event Details
Notify me if this event changes.Add this event to my personal calendar.
Go Back
Local Drug Delivery To Reduce Secondary Injury and Promote Remyelination After Spinal Cord Injury
Start Date: 9/1/2016Start Time: 10:00 AM
End Date: 9/1/2016End Time: 12:00 PM

Event Description
BIOMED PhD Research Proposal

Title:
Local Drug Delivery To Reduce Secondary Injury and Promote Remyelination After Spinal Cord Injury

Speaker:
Robert Shultz, PhD Candidate, School of Biomedical Engineering, Science and Health Systems

Advisor:
Yinghui Zhong, PhD, Assistant Professor, School of Biomedical Engineering, Science and Health Systems

Abstract:
Spinal cord injury is a debilitating condition that results in severe motor, sensory, and autonomic functional deficit. Following initial mechanical injury, a wave of toxic, inflammatory, and inhibitory molecule expression known as secondary injury causes extensive tissue loss and further functional decline. While some axons persist even through secondary injury progression, secondary injury-associated oligodendrocyte (OL) loss causes widespread demyelination, resulting in poor signal propagation and leaving axons vulnerable to additional insult. Endogenous progenitor populations capable of differentiating into mature, myelinating OLs proliferate in response to injury, but fail to efficiently differentiate, resulting in limited remyelination of denuded axons. Failed progenitor differentiation is attributed to the presence of differentiation-inhibitory signals in the post-injury microenvironment.

We aim to promote functional recovery following SCI by simultaneously attenuating secondary injury progression and directly stimulating OL differentiation. In this study, we will develop and characterize clinically relevant, biomaterials-based drug delivery systems to simultaneously attenuate secondary injury progression and promote OL differentiation to improve functional recovery in a clinically relevant rat contusion model. We hypothesize that targeting both secondary injury and remyelination will reduce inflammation, reduce lesion size, mitigate tissue loss, promote oligogenesis, and enhance myelination of axons, resulting in significantly better functional recovery than either approach alone.
Contact Information:
Name: Ken Barbee
Phone: 215-895-1335
Email: barbee@drexel.edu
Robert Schulutz
Location:
Bossone Research Center, Room 709, located at 32nd and Market Streets.
Audience:
  • Undergraduate Students
  • Graduate Students
  • Faculty
  • Staff

  • Display Month:

    Advanced Search (New Search)
    Date Range:
    Time Range:
    Category(s):
    Audience: 

    Special Features: 

    Keyword(s):
    Submit
    Select item(s) to Search
    Select item(s) to Search
    Select item(s) to Search
    Select item(s) to Search